Wealthfront Advisers’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.42M | Sell |
4,615
-1,560
| -25% | -$819K | 0.01% | 530 |
|
|
2025
Q1 | $3.92M | Sell |
6,175
-1,173
| -16% | -$744K | 0.01% | 403 |
|
|
2024
Q4 | $5.23M | Sell |
7,348
-2,141
| -23% | -$1.53M | 0.02% | 320 |
|
|
2024
Q3 | $9.98M | Sell |
9,489
-97
| -1% | -$102K | 0.03% | 165 |
|
|
2024
Q2 | $10.1M | Sell |
9,586
-154
| -2% | -$162K | 0.03% | 152 |
|
|
2024
Q1 | $9.37M | Buy |
9,740
+129
| +1% | +$124K | 0.03% | 151 |
|
|
2023
Q4 | $8.44M | Buy |
9,611
+145
| +2% | +$127K | 0.03% | 151 |
|
|
2023
Q3 | $7.79M | Sell |
9,466
-1,179
| -11% | -$970K | 0.03% | 153 |
|
|
2023
Q2 | $7.65M | Sell |
10,645
-5,943
| -36% | -$4.27M | 0.03% | 157 |
|
|
2023
Q1 | $13.6M | Buy |
16,588
+6,294
| +61% | +$5.17M | 0.06% | 87 |
|
|
2022
Q4 | $7.43M | Sell |
10,294
-75
| -0.7% | -$54.1K | 0.04% | 147 |
|
|
2022
Q3 | $7.14M | Buy |
10,369
+1,749
| +20% | +$1.2M | 0.04% | 127 |
|
|
2022
Q2 | $5.1M | Buy |
8,620
+4,881
| +131% | +$2.89M | 0.03% | 181 |
|
|
2022
Q1 | $2.61M | Buy |
3,739
+40
| +1% | +$27.9K | 0.01% | 339 |
|
|
2021
Q4 | $2.34M | Buy |
3,699
+130
| +4% | +$82.1K | 0.01% | 348 |
|
|
2021
Q3 | $2.16M | Buy |
3,569
+76
| +2% | +$46K | 0.01% | 331 |
|
|
2021
Q2 | $1.95M | Sell |
3,493
-2,990
| -46% | -$1.67M | 0.01% | 311 |
|
|
2021
Q1 | $3.07M | Sell |
6,483
-1,221
| -16% | -$578K | 0.02% | 178 |
|
|
2020
Q4 | $3.72M | Buy |
7,704
+3,301
| +75% | +$1.59M | 0.02% | 125 |
|
|
2020
Q3 | $2.47M | Sell |
4,403
-678
| -13% | -$380K | 0.02% | 146 |
|
|
2020
Q2 | $3.17M | Buy |
5,081
+4,205
| +480% | +$2.62M | 0.02% | 110 |
|
|
2020
Q1 | $428K | Buy |
876
+165
| +23% | +$80.6K | ﹤0.01% | 363 |
|
|
2019
Q4 | $267K | Buy |
+711
| New | +$267K | ﹤0.01% | 458 |
|
|
2019
Q3 | – | Sell |
-1,324
| Closed | -$414K | – | 487 |
|
|
2019
Q2 | $414K | Sell |
1,324
-166
| -11% | -$51.9K | ﹤0.01% | 406 |
|
|
2019
Q1 | $612K | Buy |
1,490
+439
| +42% | +$180K | 0.01% | 335 |
|
|
2018
Q4 | $393K | Buy |
+1,051
| New | +$393K | ﹤0.01% | 368 |
|